Functional Assessment of ADL in Patients Who Underwent Bifocal and Trifocal Presbyopic Correction

Sponsor
Democritus University of Thrace (Other)
Overall Status
Unknown status
CT.gov ID
NCT03021512
Collaborator
(none)
80
1
12
6.7

Study Details

Study Description

Brief Summary

Patients who underwent bilateral bifocal or trifocal lenses implantation for presbyopia correction with monofocal intraocular lenses implantation are supposed to have sufficient uncorrected vision capacity for activities of daily living (ADLs) that require: a) distant vision (DV), (ie. driving), b) intermediate vision (IV), (ie. computer word processing), c) near vision (NV), (ie. book reading). Primary objective of the study is the comparison in a series of ADLs of two cohorts of patients (group 1: subjects with bilateral bifocal lenses implantation, group 2: subjects with bilateral trifocal lenses implantation)

Condition or Disease Intervention/Treatment Phase
  • Procedure: Phaco with Restor
  • Procedure: Phaco with Panoptix

Study Design

Study Type:
Observational
Anticipated Enrollment :
80 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Retrospective Functional Assessment of Activities of Daily Living (ADL) in Patients Who Underwent Bilateral Implantation of Aspheric Bifocal Intraocular Lenses or Aspheric Trifocal Intraocular Lenses
Study Start Date :
Jan 1, 2017
Anticipated Primary Completion Date :
Jan 1, 2018
Anticipated Study Completion Date :
Jan 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Group 1 (BFG)

(Bifocal group). Subjects that underwent bifocal intraocular lenses implantation. (ie. Phaco with Restor intervention).

Procedure: Phaco with Restor
Phacoemulsification with bilateral bifocal intraocular lenses implantation

Group 2 (TFG)

(Trifocal group). Subjects that underwent trifocal intraocular lenses implantation. (ie. Phaco with Panoptix intervention).

Procedure: Phaco with Panoptix
Phacoemulsification with bilateral trifocal intraocular lenses implantation

Outcome Measures

Primary Outcome Measures

  1. Visual Capacity (VC) [1 year following surgery]

    Assessment of Visual capacity (VC)

Secondary Outcome Measures

  1. Distant Visual Capacity (DVC) [1 year following surgery]

    Visual capacity for activities that require distant vision (DVC). DVC score will be measured by the performance score in the following ADLs: a) walking specific pathway, 2) walking up stairs, 3) walking down stairs, 4) day-time driving simulation, 5) night-time driving simulation

  2. Intermediate Visual Capacity (IVC) [1 year following surgery]

    Visual Capacity for activities that require intermediate vision (IVC). VC score will be measured by the performance score in the following ADLs: a) reading ability of movie subtitles, b) reading ability of a predefined computer screen text, c) reading a supermarket badge

  3. Near Visual Capacity (NVC) [1 year follwoing surgery]

    Visual Capacity for activities that require near vision (NVC). NVC score will be measured by the performance score in the following ADLs: a) cellular phone directory entry search, b) reading of message in a cellular phone, c) reading a medical prescription, d) reading a public phonebook

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Presbyopic patients that underwent either bilateral bifocal or trifocal intraocular lenses implantation
Exclusion Criteria:
  • Glaucoma, Corneal pathology, Fundus pathology, Mental or Neurological disorder

Contacts and Locations

Locations

Site City State Country Postal Code
1 Democritus University of Thrace Alexandhroupolis Evros Greece 68100

Sponsors and Collaborators

  • Democritus University of Thrace

Investigators

  • Principal Investigator: Georgios Labiris, MD, PhD, Assistant Professor

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Georgios Labiris, Assistant Professor, Democritus University of Thrace
ClinicalTrials.gov Identifier:
NCT03021512
Other Study ID Numbers:
  • 299/13-1-2017
First Posted:
Jan 16, 2017
Last Update Posted:
Jan 16, 2017
Last Verified:
Jan 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 16, 2017